{"schema_version":"secwatch.filing_event.v1","accession":"0001062822-25-000035","form_type":"8-K","ticker":"LXRX","cik":"0001062822","company_name":"LEXICON PHARMACEUTICALS, INC.","filed_at":"2025-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.231345+00:00","generated_at":"2026-05-18T09:24:32.339852+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lexicon gets Nasdaq 180-day extension to regain $1 bid; stock moves to Capital Market","bullets":["Nasdaq granted additional 180-day period until Dec 30, 2025 for Lexicon to cure $1 bid price deficiency.","Common stock will transfer from Nasdaq Global Select to Capital Market on July 7, 2025.","Compliance requires closing bid ≥ $1 for ten consecutive business days during the extension period.","Eligibility conditioned on meeting other listing requirements and intent to pursue reverse stock split if necessary."],"urls":{"canonical":"https://secwatch.observer/filing/0001062822-25-000035","json":"https://secwatch.observer/filing/0001062822-25-000035.json","markdown":"https://secwatch.observer/filing/0001062822-25-000035.md","text":"https://secwatch.observer/filing/0001062822-25-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1062822/000106282225000035/0001062822-25-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1062822/000106282225000035/lxrx-20250703.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:24:32.339852+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}